AAAAAA

   
Results: 1-7 |
Results: 7
Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study
Authors: Lygidakis, NJ Sgourakis, G Dedemadi, G Safioleus, MC Nestoridis, J
Citation: Nj. Lygidakis et al., Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study, HEP-GASTRO, 48(40), 2001, pp. 1085-1087
Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma
Authors: Lygidakis, NJ Sgourakis, G Dedemadi, G Spentzouris, N Kontis, A Nestoridis, J
Citation: Nj. Lygidakis et al., Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma, HEP-GASTRO, 47(36), 2000, pp. 1546-1554
New frontiers in liver surgery. Two-stage liver surgery for the managementof advanced metastatic liver disease
Authors: Lygidakis, NJ Vlachos, L Raptis, S Rassidakis, G Balaskas, G Sgourakis, G Mourikis, D Kehagias, D Kittas, C
Citation: Nj. Lygidakis et al., New frontiers in liver surgery. Two-stage liver surgery for the managementof advanced metastatic liver disease, HEP-GASTRO, 46(28), 1999, pp. 2216-2228
Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma
Authors: Lygidakis, NJ Vlachos, L Raptis, S Sgourakis, G Mourikis, D Kehagias, D
Citation: Nj. Lygidakis et al., Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma, HEP-GASTRO, 46(28), 1999, pp. 2229-2239
Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regionalchemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial
Authors: Lygidakis, NJ Sgourakis, G Aphinives, P
Citation: Nj. Lygidakis et al., Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regionalchemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial, HEP-GASTRO, 46(27), 1999, pp. 2035-2038
Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study
Authors: Lygidakis, NJ Safioleas, M Sgourakis, G Aphinives, P
Citation: Nj. Lygidakis et al., Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study, HEP-GASTRO, 46(26), 1999, pp. 792-798
Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease
Authors: Lygidakis, NJ Safioleas, M Sgourakis, G Spentzouris, N Dedemadi, G Sotiropoulou, P
Citation: Nj. Lygidakis et al., Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease, HEP-GASTRO, 46(25), 1999, pp. 148-156
Risultati: 1-7 |